Neogen Corporation (NEOG) earnings
NEOG earnings moved a median of +1.09% by the close. Quarterly and annual NEOG reports and results, each read against the price at its own news timestamp. Back to the NEOG overview →
33 measured NEOG earnings events.
Where these NEOG earnings landedvs 32 measured NEOG earnings reactions
| Middle 50% of NEOG earnings reactions | -1.10% to +2.75% |
|---|---|
| Median reaction (to close) | +1.09% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 NEOG earnings events with a measured close landed between -1.10% and +2.75%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NEOGEN CORP For: Aug 31 | SEC filing · Form 10-Q | -2.09% | +1.83% | |
| Neogen Announces First-Quarter Earnings Release Date | Press release | +0.98% | +2.03% | |
| Form 10-K NEOGEN CORP For: May 31 | SEC filing · Form 10-K | -1.07% | +2.73% | |
| Form 10-Q NEOGEN CORP For: Feb 28 | SEC filing · Form 10-Q | -3.21% | -5.42% | |
| Form 10-Q NEOGEN CORP For: Nov 30 | SEC filing · Form 10-Q | -3.51% | -3.61% | |
| Neogen Announces Second-Quarter 2026 Results | Press release | +4.50% | +4.97% | |
| Neogen Announces Second-Quarter Earnings Release Date | Press release | +0.98% | +4.62% | |
| Form 10-Q NEOGEN CORP For: Aug 31 | SEC filing · Form 10-Q | +0.07% | +0.30% | |
| Neogen Announces First-Quarter 2026 Results | Press release | +2.27% | +2.73% | |
| Neogen Announces First-Quarter Earnings Release Date | Press release | -0.18% | -1.06% | |
| Form 10-K NEOGEN CORP For: May 31 | SEC filing · Form 10-K | +0.00% | -1.68% | |
| Neogen Announces Fourth-Quarter 2025 Results | Press release | -4.23% | — | |
| Neogen Announces Fourth-Quarter Earnings Release Date | Press release | +0.95% | +4.96% | |
| Form 10-Q NEOGEN CORP For: Feb 28 | SEC filing · Form 10-Q | +0.97% | +9.53% | |
| Neogen Announces Third-Quarter 2025 Results | Press release | -17.34% | -7.38% | |
| Neogen Announces Third-Quarter Earnings Release Date | Press release | -0.91% | +0.00% | |
| Form 10-Q NEOGEN CORP For: Nov 30 | SEC filing · Form 10-Q | -1.00% | -1.22% | |
| Form NT 10-Q NEOGEN CORP For: Nov 30 | SEC filing · Form NT | -0.65% | +2.81% | |
| Neogen Announces Preliminary¹ Second-Quarter 2025 Results | Press release | +1.07% | +5.55% | |
| Neogen® Announces Change to Second-Quarter Earnings Release Date | Press release | -0.04% | +2.17% | |
| Neogen® Announces Second-Quarter Earnings Release Date | Press release | +1.59% | +0.92% | |
| Form 10-Q NEOGEN CORP For: Aug 31 | SEC filing · Form 10-Q | +0.15% | +1.25% | |
| Neogen Announces First-Quarter 2025 Results | Press release | -2.81% | -5.42% | |
| Neogen® Announces First-Quarter Earnings Release Date | Press release | -0.67% | -2.29% | |
| Form 10-K NEOGEN CORP For: May 31 | SEC filing · Form 10-K | +1.05% | +0.06% | |
| Neogen Announces Fourth-Quarter 2024 Results | Press release | +1.74% | -0.96% | |
| Neogen Announces Fourth-Quarter Earnings Release Date | Press release | +0.12% | +0.18% | |
| Form 10-Q NEOGEN CORP For: Feb 29 | SEC filing · Form 10-Q | -0.73% | -2.50% | |
| Neogen Announces Third-Quarter 2024 Results | Press release | +3.29% | +2.19% | |
| Neogen Announces Third-Quarter Earnings Release Date | Press release | +0.13% | +3.24% | |
| Form 10-Q NEOGEN CORP For: Nov 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Neogen Announces Second-Quarter 2024 Results | Press release | +8.56% | +11.19% | |
| Neogen Announces Second-Quarter Earnings Release Date | Press release | +0.05% | +2.17% |
Keep exploring
More NEOG: analyst actions → · SEC filings → · NEOG overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 1,147 | -0.01% | 50% |
| Epizyme, Inc. (EPZM) | 1,145 | +0.04% | 51% |
| Pacira BioSciences, Inc. (PCRX) | 1,143 | -0.04% | 48% |
| Anthem, Inc. (ANTM) | 1,140 | -0.01% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.